Tony Kingsley

CEO at Stablix

Tony Kingsley is the current CEO at Stablix. Prior to this, they were the President & CEO at Scholar Rock from July 2020 to August 2021. Tony has also served as the President & Chief Operating Officer at The Medicines Company from May 2016 to January 2018, and as the EVP Global Commercial at Biogen from January 2010 to December 2015. In December 2018, they became the President & CEO at TARIS Bio, a position they held until December 2019. Most recently, they were the SVP at Hologic / Cytyc Corporation from January 2006 to December 2009.

Moses Moustakim - Senior Scientist, Lead Chemist, Uddhav Shigdel - Principal Scientist, Head of Biomolecular Sciences, and Kevin Sprott - Co-Founder & SVP, Drug Discovery report to Tony Kingsley.

Location

Boston, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Stablix

Stablix is pioneering an entirely new field of targeted protein stabilization (TPS) to bring transformative medicines to patients with unmet medical need.


Employees

11-50

Links